Engineers developed a robotic replica of the heart's right ventricle, which mimics the beating and blood-pumping action of live hearts. The device could be used for studying right ventricle disorders ...

In a recent study published in Nature Cardiovascular Research, researchers modeled the right ventricle (RV) to create a robot replicating right ventricular hemodynamics and biomechanics. Study: ...

MIT engineers have developed a robotic replica of the heart's right ventricle, which mimics the beating and blood-pumping action of live hearts. The robo-ventricle combines real heart tissue with ...

MIT engineers have developed a robotic replica of the heart’s right ventricle, which mimics the beating and blood-pumping action of live hearts. The robo-ventricle combines real heart tissue with ...

Trisol's Transcatheter Tricuspid Valve Replacement (TTVR) system is designed to treat severe to torrential tricuspid regurgitation (TR), a condition in which the tricuspid valve fails to close ...

Please provide your email address to receive an email when new articles are posted on . Sacubitril/valsartan was safe and effective for reverse remodeling and improving systolic function and ...

No parent wants to find out that their child has a heart condition, but fortunately, children with ventricle defects can be helped with many different types of research-backed treatments and ...

BioVentrix has collected $48.5 million in venture capital funding to help carry its treatment for ischemic heart failure to an FDA review. The former Fierce Medtech Fierce 15 winner’s minimally ...

BOSTON--(BUSINESS WIRE)--Ancora Heart, Inc., a company developing a completely transcatheter device-based therapy to address heart failure (HF), today announced that patients treated with the ...